Supportive resources for your PLUVICTO journey
Here are some materials you can use to learn more about PSMA+ mCRPC and PLUVICTO. You can download, print, and revisit them at any stage in your or your loved ones' treatment.
Here are some materials you can use to learn more about PSMA+ mCRPC and PLUVICTO. You can download, print, and revisit them at any stage in your or your loved ones' treatment.
What is the most important information I should know about PLUVICTO?
Use of PLUVICTO involves exposure to radioactivity. Long-term, accruing radiation exposure is associated with an increased risk for cancer...
What is PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)?
PLUVICTO is a radiopharmaceutical used to treat adults with an advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that...